Sri Lanka will purchase 2 to 3 million doses of Oxford-AstraZeneca vaccine from its Indian manufacturing company Serum Institute of India during the next two days, a top Sri Lankan official said here on Wednesday.
Lalith Weeratunga, the advisor to President Gotabaya Rajapaksa said that purchasing from India will follow Thursday's arrival of India's free vaccines to Sri Lanka.
He said the Indian Covishield vaccine is to arrive tomorrow and the consignment will be accepted by President Rajapaksa at the Colombo international airport.
A total of 250,000 people, mostly health frontline workers, members of the security forces and police and the vulnerable aged, will get the vaccine on a priority basis.
The vaccination programme for which dry runs were made over the weekend will commence on Friday.
Weeratunga added that 300,000 free vaccines from China are also due and the government would be requesting Russia also for the vaccine.
Sri Lanka has recorded a near 60,000 cases till January 26, with 288 deaths from the pandemic since it was found in the island nation in mid March last year.
India is one of the world's biggest drug makers and an increasing number of countries have already approached it for procuring the coronavirus vaccines.
In the last few days, India has sent consignments of domestically produced coronavirus vaccines under grant assistance to Bhutan, Maldives, Nepal, Bangladesh, Myanmar, Mauritius and Seychelles.
It is also undertaking commercial supplies of the doses to a number of countries, including Saudi Arabia, South Africa, Brazil and Morocco.
(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)
Dear Reader,
Business Standard has always strived hard to provide up-to-date information and commentary on developments that are of interest to you and have wider political and economic implications for the country and the world. Your encouragement and constant feedback on how to improve our offering have only made our resolve and commitment to these ideals stronger. Even during these difficult times arising out of Covid-19, we continue to remain committed to keeping you informed and updated with credible news, authoritative views and incisive commentary on topical issues of relevance.
We, however, have a request.
As we battle the economic impact of the pandemic, we need your support even more, so that we can continue to offer you more quality content. Our subscription model has seen an encouraging response from many of you, who have subscribed to our online content. More subscription to our online content can only help us achieve the goals of offering you even better and more relevant content. We believe in free, fair and credible journalism. Your support through more subscriptions can help us practise the journalism to which we are committed.
Support quality journalism and subscribe to Business Standard.
Digital Editor
RECOMMENDED FOR YOU